Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo (Q34277742)

1 August 2017

title

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo (English)

1 reference

1 August 2017

0 references

0 references

Wang Z

1

1 reference

1 August 2017

Ma HI

2

1 reference

1 August 2017

Li J

3

1 reference

1 August 2017

Sun L

4

1 reference

1 August 2017

Zhang J

5

1 reference

1 August 2017

Xiao X

6

1 reference

1 August 2017

publication date

1 December 2003

1 reference

1 August 2017

1 reference

1 August 2017

volume

10

1 reference

1 August 2017

issue

26

1 reference

1 August 2017

page(s)

2105-2111

1 reference

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Design and packaging of adeno-associated virus gene targeting vectors

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Transcription and DNA supercoiling

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Gene expression from adeno-associated virus vectors in airway epithelial cells

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

RNA interference in adult mice.

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302133

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302133

1 reference

1 August 2017

1 reference